99196-41-5

Upstream product

• 504-02-9 1,3-cylohexanedione 
• 870-63-3 prenyl bromide 

Downstream Products

• 657401-96-2 2-(2-allyloxy-benzoyl)-4-(3-methyl-but-2-enyl)-cyclohexane-1,3-dione 
• 657401-97-3 2-[2-(2-methyl-allyloxy)-benzoyl]-4-(3-methyl-but-2-enyl)-cyclohexane-1,3-dione 
• 657402-06-7 2-[1-Methoxy-1-[2-(2-methyl-allyloxy)-phenyl]-meth-(E)-ylidene]-4-(3-methyl-but-2-enyl)-cyclohexane-1,3-dione 
• 657402-02-3 3-methoxy-2-[2-(2-methyl-allyloxy)-benzoyl]-6-(3-methyl-but-2-enyl)-cyclohex-2-enone 
• 657402-05-6 2-[1-(2-Allyloxy-phenyl)-1-methoxy-meth-(E)-ylidene]-4-(3-methyl-but-2-enyl)-cyclohexane-1,3-dione 
• 657402-01-2 2-(2-allyloxy-benzoyl)-3-methoxy-6-(3-methyl-but-2-enyl)-cyclohex-2-enone 

Relevant academic research and scientific papers

Olefin Metathesis: Remote Substituents Governing the Stereoselectivity of 11-Membered-Ring Formation

(Matrix presented) Stereospecific RCM reaction of 7 (R1 = Me) results in the formation of (Z)-11-membered macrocycle 9c. Cascade RCM/ROM/RCM transformation of 7 (R1 = H) affords the thermodynamically more stable spirocycle product 12.

Pyrazolopyridine cycloalkanones and process for their preparation

Novel tetrahydropyrazolo-[3,4-b]quinolinones, cyclopenta[b]pyrazolo-[4,3-e]pyridinones and cyclohepta[b]-pyrazolo[4,3-e]pyridinones, useful as anxiolytics having reduced side effects, are disclosed, including methods of preparation, pharmaceutical compositions containing them and intermediates used in their preparation.